Search Ontology:
ChEBI
ASP-3026
- Term ID
- CHEBI:167650
- Synonyms
-
- 2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]-4-N-(2-propan-2-ylsulfonylphenyl)-1,3,5-triazine-2,4-diamine
- ASP 3026
- ASP3026
- N(2)-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N(4)-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine
- N-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}-N'-[2-(propan-2-ylsulfonyl)phenyl]-1,3,5-triazine-2,4-diamine
- Definition
- A member of the class of diamino-1,3,5-triazines that is 1,3,5-triazine-2,4-diamine in which the amino groups at positions 2 and 4 are respectively carrying 2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl and 2-(propan-2-ylsulfonyl)phenyl substituents. It is a potent inhibitor of anaplastic lymphoma kinase (ALK), Ack and ROS1 activity (IC50 values are 3.5, 5.8 and 8.9 nM respectively) and exhibits anti-cancer properties.
- References
-
- cas:1097917-15-1
- chemspider:28424239
- drugbank:DB12729
- pdb-ccd:F6O
- pubmed:24419060
- pubmed:25026277
- pubmed:25727400
- pubmed:25749034
- pubmed:25888090
- pubmed:26020125
- pubmed:26027465
- pubmed:26964870
- pubmed:26966027
- pubmed:27565932
- pubmed:28930717
- pubmed:29491259
- pubmed:31177400
- pubmed:31340850
- pubmed:33053158
- pubmed:33331996
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from ASP-3026
Phenotype where environments contain ASP-3026
Phenotype modified by environments containing ASP-3026
Phenotype affecting ASP-3026
Human Disease Model